201 related articles for article (PubMed ID: 10607235)
1. Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro.
Gong ZJ; De Meyer S; Clarysse C; Verslype C; Neyts J; De Clercq E; Yap SH
J Viral Hepat; 1999 May; 6(3):229-36. PubMed ID: 10607235
[TBL] [Abstract][Full Text] [Related]
2. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
3. The addition of mycophenolate mofetil for suppressing hepatitis B virus replication in liver recipients who developed lamivudine resistance--no beneficial effect.
Ben-Ari Z; Zemel R; Tur-Kaspa R
Transplantation; 2001 Jan; 71(1):154-6. PubMed ID: 11211184
[TBL] [Abstract][Full Text] [Related]
4. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
[TBL] [Abstract][Full Text] [Related]
5. The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1alpha,2beta,3alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl]guanine against different herpes viruses.
Neyts J; De Clercq E
Transplantation; 1999 Mar; 67(5):760-4. PubMed ID: 10096537
[TBL] [Abstract][Full Text] [Related]
6. The effect of mycophenolate acid on hepatitis B virus replication in vitro.
Wu J; Xie HY; Jiang GP; Xu X; Zheng SS
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):410-3. PubMed ID: 14599949
[TBL] [Abstract][Full Text] [Related]
7. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
Ying C; De Clercq E; Neyts J
Antiviral Res; 2000 Nov; 48(2):117-24. PubMed ID: 11114413
[TBL] [Abstract][Full Text] [Related]
8. The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.
Hoppe-Seyler K; Sauer P; Lohrey C; Hoppe-Seyler F
Hepatology; 2012 Jul; 56(1):9-16. PubMed ID: 22271223
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection in microcarrier-attached immortalized human hepatocytes cultured in molecularporous membrane bags: a model for long-term episomal replication of HBV.
Gong ZJ; De Meyer S; Roskams T; van Pelt JF; Soumillion A; Crabbé T; Yap SH
J Viral Hepat; 1998 Nov; 5(6):377-87. PubMed ID: 9857347
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus (HBV)-specific short hairpin RNA is capable of reducing the formation of HBV covalently closed circular (CCC) DNA but has no effect on established CCC DNA in vitro.
Starkey JL; Chiari EF; Isom HC
J Gen Virol; 2009 Jan; 90(Pt 1):115-26. PubMed ID: 19088280
[TBL] [Abstract][Full Text] [Related]
11. RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.
Wooddell CI; Yuen MF; Chan HL; Gish RG; Locarnini SA; Chavez D; Ferrari C; Given BD; Hamilton J; Kanner SB; Lai CL; Lau JYN; Schluep T; Xu Z; Lanford RE; Lewis DL
Sci Transl Med; 2017 Sep; 9(409):. PubMed ID: 28954926
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.
Ruan J; Sun S; Cheng X; Han P; Zhang Y; Sun D
Virol J; 2020 Jul; 17(1):89. PubMed ID: 32611423
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
14. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
[TBL] [Abstract][Full Text] [Related]
15. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA.
Nkongolo S; Nußbaum L; Lempp FA; Wodrich H; Urban S; Ni Y
Antiviral Res; 2019 Aug; 168():146-155. PubMed ID: 31018112
[TBL] [Abstract][Full Text] [Related]
16. Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.
Li J; Zong L; Sureau C; Barker L; Wands JR; Tong S
J Virol; 2016 Sep; 90(18):8302-13. PubMed ID: 27384660
[TBL] [Abstract][Full Text] [Related]
17. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production.
Phillips S; Chokshi S; Chatterji U; Riva A; Bobardt M; Williams R; Gallay P; Naoumov NV
Gastroenterology; 2015 Feb; 148(2):403-14.e7. PubMed ID: 25305505
[TBL] [Abstract][Full Text] [Related]
18. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
19. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
